Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

NCT05312671 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Neuroendocrine Carcinoma of Bladder
Bladder Cancer
Urothelial Carcinoma Bladder

Interventions

DRUG: Atezolizumab
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Etoposide
PROCEDURE: Cystectomy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]